Fellowship in Gastrointestinal and Liver Pathology... Read More
India’s Most Comprehensive Lymphoedema Treatment... Read More
Amrita Hospital Receives Prestigious British Medic... Read More
India’s First Centre for Aortic Diseases Opens a... Read More
Amrita Institute of Medical Sciences Bags Two Heal... Read More
Top National Rankings for Amrita's Ophthalmology a... Read More
Amrita Hospital Conducts India’s First Double F... Read More
Amrita Institute of Medical Sciences Bags Manavase... Read More
Vacancy for the post of Staff Nurses 2016... Read More
2000-Bed Amrita Institute of Medical Sciences to C... Read More
Elderly woman undergoes heart valve replacement wi... Read More
Vacancies for the post of Lectures/Clinical Assist... Read More
Scroll of Honour for Amrita Institute of Medical S... Read More
Infection Control Certification Programme for Nurs... Read More
The Royal College of Surgeons of England welcomes ... Read More
Lung transplantation is a life changing decision and for those carefully selected patients with end stage lung disease has become an accepted therapy for those who have not benefited from available therapies. The treatment is highly successful, with more than 80 percent of patients surviving the first year and greater than 50% of patients surviving beyond five years. The quality of life of long-term survivors is excellent, with the majority returning to productive activities. These results are possible because of the development of specialized care teams and the application of rigorous patient-care protocols, both in the hospital and for the long term.
The lung transplantation service at Amrita Institute of Medical Sciences is a multidisciplinary integrated service which drives it strength from the blessings of Mata Amritanandamayi and the skills and expertise of its core lung transplant team which are fortunate to have trained in internationally reputed lung transplant units in the World. The world class support facilities including an ECMO, blood transfusion, pathology, microbiology, infection control, radiology services, intensivist services allows us to expect the best possible outcomes for our patients.
In general we consider lung transplantation in persons with end stage lung disease who are less than 60 years of age for a double lung or heart-lung transplant, and less than 65 for a single lung transplant. However, there is no absolute age contraindication and we consider patients based on his/her physiologic age rather than strict chronologic age. Long-term survival does favor younger patients as co-morbid illnesses increase with the ageing process.
Decision regarding the utility of the donor lung will be made by the harvesting team and anaesthetic team based on standard criteria from individuals between the age of 18-64 preferentially. These may include brain dead donors or Donation after Cardiac Death(DCD) donors. When possible the ischaemic time will be maintained to within 6 hours, however marginal donors may be considered at the discretion of the harvesting team.